Summary
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as cancer, asthma, type 2 diabetes and weight loss – Ozempic, Rybelsus and Wegovy. Austedo and Austedo XR, used to treat Huntingtons disease.
Source: AL.com on MSN.com
Exclusive AI-Powered News Insights (For Members only)
This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
